Cargando…

Response: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J 2015;39:74-81)

Detalles Bibliográficos
Autores principales: Sicras-Mainar, Antoni, Navarro-Artieda, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411550/
https://www.ncbi.nlm.nih.gov/pubmed/25922813
http://dx.doi.org/10.4093/dmj.2015.39.2.173
_version_ 1782368494241710080
author Sicras-Mainar, Antoni
Navarro-Artieda, Ruth
author_facet Sicras-Mainar, Antoni
Navarro-Artieda, Ruth
author_sort Sicras-Mainar, Antoni
collection PubMed
description
format Online
Article
Text
id pubmed-4411550
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Korean Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-44115502015-04-28 Response: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J 2015;39:74-81) Sicras-Mainar, Antoni Navarro-Artieda, Ruth Diabetes Metab J Response Korean Diabetes Association 2015-04 2015-04-20 /pmc/articles/PMC4411550/ /pubmed/25922813 http://dx.doi.org/10.4093/dmj.2015.39.2.173 Text en Copyright © 2015 Korean Diabetes Association http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Response
Sicras-Mainar, Antoni
Navarro-Artieda, Ruth
Response: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J 2015;39:74-81)
title Response: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J 2015;39:74-81)
title_full Response: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J 2015;39:74-81)
title_fullStr Response: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J 2015;39:74-81)
title_full_unstemmed Response: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J 2015;39:74-81)
title_short Response: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J 2015;39:74-81)
title_sort response: economic impact of combining metformin with dipeptidyl peptidase-4 inhibitors in diabetic patients with renal impairment in spanish patients (diabetes metab j 2015;39:74-81)
topic Response
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411550/
https://www.ncbi.nlm.nih.gov/pubmed/25922813
http://dx.doi.org/10.4093/dmj.2015.39.2.173
work_keys_str_mv AT sicrasmainarantoni responseeconomicimpactofcombiningmetforminwithdipeptidylpeptidase4inhibitorsindiabeticpatientswithrenalimpairmentinspanishpatientsdiabetesmetabj2015397481
AT navarroartiedaruth responseeconomicimpactofcombiningmetforminwithdipeptidylpeptidase4inhibitorsindiabeticpatientswithrenalimpairmentinspanishpatientsdiabetesmetabj2015397481